- Home
- USEA vs TNON Comparison
USEA vs TNON Comparison
Compare USEA & TNON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USEA
- TNON
- Stock Information
- Founded
- USEA 2004
- TNON 2012
- Country
- USEA Greece
- TNON United States
- Employees
- USEA N/A
- TNON N/A
- Industry
- USEA Marine Transportation
- TNON Medical Specialities
- Sector
- USEA Consumer Discretionary
- TNON Health Care
- Exchange
- USEA Nasdaq
- TNON Nasdaq
- Market Cap
- USEA 10.5M
- TNON 11.5M
- IPO Year
- USEA N/A
- TNON 2022
- Fundamental
- Price
- USEA $1.70
- TNON $1.19
- Analyst Decision
- USEA
- TNON Strong Buy
- Analyst Count
- USEA 0
- TNON 2
- Target Price
- USEA N/A
- TNON $5.50
- AVG Volume (30 Days)
- USEA 22.3K
- TNON 340.6K
- Earning Date
- USEA 08-06-2025
- TNON 11-12-2025
- Dividend Yield
- USEA 2.37%
- TNON N/A
- EPS Growth
- USEA N/A
- TNON N/A
- EPS
- USEA N/A
- TNON N/A
- Revenue
- USEA $42,625,000.00
- TNON $2,947,000.00
- Revenue This Year
- USEA N/A
- TNON $43.52
- Revenue Next Year
- USEA N/A
- TNON $82.14
- P/E Ratio
- USEA N/A
- TNON N/A
- Revenue Growth
- USEA N/A
- TNON N/A
- 52 Week Low
- USEA $1.00
- TNON $0.85
- 52 Week High
- USEA $2.78
- TNON $15.79
- Technical
- Relative Strength Index (RSI)
- USEA 61.69
- TNON 44.73
- Support Level
- USEA $1.66
- TNON $1.11
- Resistance Level
- USEA $1.78
- TNON $1.26
- Average True Range (ATR)
- USEA 0.05
- TNON 0.07
- MACD
- USEA 0.00
- TNON -0.02
- Stochastic Oscillator
- USEA 63.64
- TNON 20.51
About USEA United Maritime Corporation
United Maritime Corp operates as a shipping company currently specializing in the seaborne transportation of dry bulk commodities. It currently operates one LR2 tanker vessel and three Capesize dry bulk vessels, two Kamsarmax dry bulk vessels, and three Panamax dry bulk vessels, with an aggregate cargo-carrying capacity of approximately 1,004,289 dwt.
About TNON Tenon Medical Inc.
Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.